Traders purchased shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Tuesday. $197.45 million flowed into the stock on the tick-up and $143.25 million flowed out of the stock on the tick-down, for a money net flow of $54.20 million into the stock. Of all companies tracked, UnitedHealth Group had the 32nd highest net in-flow for the day. UnitedHealth Group traded down ($2.71) for the day and closed at $226.66
UNH has been the subject of several research analyst reports. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Evercore ISI reissued an “outperform” rating and set a $255.00 price target (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Wells Fargo & Co reissued an “outperform” rating and set a $245.00 price target (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target for the company in a report on Saturday, January 20th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $243.22.
The firm has a market capitalization of $219,650.00, a P/E ratio of 23.86, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.11 earnings per share. sell-side analysts anticipate that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.
In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,396 shares of company stock valued at $12,262,067. Corporate insiders own 0.89% of the company’s stock.
Several large investors have recently bought and sold shares of UNH. BlackRock Inc. raised its position in UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock valued at $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. raised its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC raised its position in UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock valued at $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. Geode Capital Management LLC raised its position in UnitedHealth Group by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 9,969,166 shares of the healthcare conglomerate’s stock valued at $2,193,088,000 after purchasing an additional 395,090 shares during the period. Finally, Alliancebernstein L.P. raised its position in UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after purchasing an additional 174,290 shares during the period. Institutional investors own 85.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.